Search Results
CLL11 trial: tackling tough-to-treat CLL patients with co-morbidities
Obinutuzumab increases survival in CLL patients with comorbidities
CLL11 trial shows improved OS rates in CLL with obinutuzumab
How to treat a previously untreated CLL patient
Obinutuzumab/chlorambucil gives OS benefit over rituximab in frontline CLL
EHA 2013: Adding obinutuzumab or rituximab to chlorambucil improves chronic lymphocytic leukaemia
Treating CLL with obiutuzumab
Venetoclax for the Treatment of Elderly Patients With CLL
Predicting resistance in CLL patients
Chronic lymphocytic leukaemia: Transition to a new era
Patient Selection for CLL Treatment
Lessening the Risk for Infusion Reactions with Novel CLL Therapies
